Bithionol inhibits ovarian cancer cell growth In Vitro - studies on mechanism(s) of action

Drug resistance is a cause of ovarian cancer recurrence and low overall survival rates. There is a need for more effective treatment approaches because the development of new drug is expensive and time consuming.